Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 18/20 | 0.39 |
| ▸ | MLNR | O43193 | 1/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | DRD1 | P21728 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18311827 | 0.97 | PDK2 (0.39) | PDK2MLNRNR1I2CHRM2ADRB1 | |
| SCHEMBL12378996 | 0.96 | PDK2 (0.39) | PDK2 | |
| SCHEMBL12378967 | 0.96 | PDK2 (0.43) | PDK2 | |
| SCHEMBL19448857 | 0.96 | PDK2 (0.41) | PDK2 | |
| SCHEMBL12378963 | 0.94 | PDK2 (0.43) | PDK2 | |
| SCHEMBL17465480 | 0.94 | PDK2 (0.43) | PDK2 | |
| SCHEMBL13104646 | 0.94 | PDK2 (0.40) | PDK2 | |
| SCHEMBL12379111 | 0.94 | PDK2 (0.42) | PDK2 | |
| SCHEMBL12378952 | 0.93 | PDK2 (0.44) | PDK2 | |
| SCHEMBL17180537 | 0.93 | PDK2 (0.43) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8288018-B2 | Amino compound for organic light-emitting device and organic light-emitting device including the same | CANON KABUSHIKI KAISHA (JP) | 2012-10-16 | — | — | US | disclosed |
| US-8288018-B2 | Amino compound for organic light-emitting device and organic light-emitting device including the same | CANON KABUSHIKI KAISHA (JP) | 2012-10-16 | — | — | US | disclosed |
| US-20110198576-A1 | AMINO COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2011-08-18 | — | — | US | disclosed |
| US-20110198576-A1 | AMINO COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2011-08-18 | — | — | US | disclosed |
| US-7960039-B2 | Amino compound for organic light-emitting device and organic light-emitting device including the same | CANON KABUSHIKI KAISHA (JP) | 2011-06-14 | — | — | US | disclosed |
| US-7960039-B2 | Amino compound for organic light-emitting device and organic light-emitting device including the same | CANON KABUSHIKI KAISHA (JP) | 2011-06-14 | — | — | US | disclosed |
| US-20070228941-A1 | AMINO COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2007-10-04 | — | — | US | disclosed |
| US-20070228941-A1 | AMINO COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070228941-A1 | AMINO COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | ARL1, APOL1, UFL1 | PDK2 2514/4885MLNR 3175/4885NR1I2 394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.